Journals / Balkan Medical Journal / 2021 / Cilt: 38 - Sayı: 5

Effects of the Rho/Rho-Kinase Pathway on Perfusion Pressure in the Isolated-Perfused Rat Hind Limb Vascular Bed

Pages
304–309
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: The Rho/ROCK pathway contributes significantly to the control of perfusion pressure in the rat hind limb vascular bed.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background: Rho/ROCK signaling has been demonstrated to be involved in the vascular reactivity of many arterial networks.
📊
Key Findings & Data:Methods: Two Rho inhibitors (atorvastatin and C3 exoenzyme) and ROCK inhibitors (Y-27632 and fasudil) were tested on the phenylephrine-elevated perfusion pressure in the isolated-perfused rat hind limb vascular bed.
💡
Conclusion & Impact:Conclusion: The Rho/ROCK pathway contributes significantly to the control of perfusion pressure in the rat hind limb vascular bed.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background: Rho/ROCK signaling has been demonstrated to be involved in the vascular reactivity of many arterial networks. However, RhoA expression and the contribution of Rho/ROCK pathway to the control of perfusion pressure have not been investigated in the rat hind limb vascular bed as a skeletal muscle vascular network. Aims: To investigate the contribution of the Rho/ROCK pathway in the control of perfusion pressure in the isolated-perfused rat hind limb vascular bed. Study Design: Animal experimentation. Methods: Two Rho inhibitors (atorvastatin and C3 exoenzyme) and ROCK inhibitors (Y-27632 and fasudil) were tested on the phenylephrine-elevated perfusion pressure in the isolated-perfused rat hind limb vascular bed. Furthermore, we sought the expression of RhoA protein in the femoral, popliteal and saphenous arteries as well as quadriceps and gastrocnemius muscles by Western blotting. Results: The ROCK inhibitors Y-27632 and fasudil (both 10−8to 10−5M) induced substantial vasodilatations. The maximum vasodilatations induced by Y-27632 and fasudil (both at 10−5M) were 84.0 ± 6.9% and 76.9 ± 6.9%, respectively (P = .091). Y-27632 was not more potent than fasudil, as the EC50 values for Y-27632 and fasudil were 0.7 ± 2.1 μM and 2.5 ± 2.4 μM, respectively (P = .177). Atorvastatin (10−7to 10−4M) and C3 exoenzyme (3 × 10−8M) also produced vasodilatation (maximum vasodilatation; 20.3 ± 1.7% and 13.7 ± 3.6%, respectively). The EC50 value for atorvastatin was 94.9 ± 1.2 μM. The western blot analysis showed that the femoral, saphenous, and popliteal arteries, as well as the gastrocnemius and quadriceps muscles, express RhoA protein. Conclusion: The Rho/ROCK pathway contributes significantly to the control of perfusion pressure in the rat hind limb vascular bed.

🔖

Cite This Article

TİFTİK, N., BÜYÜKAFŞAR, K., İLHAN, E., SEÇİLMİŞ, M. A., ALZAYED, Z. (2022). Effects of the Rho/Rho-Kinase Pathway on Perfusion Pressure in the Isolated-Perfused Rat Hind Limb Vascular Bed. Balkan Medical Journal, Cilt: 38 - Sayı: 5, 304–309. https://ajindex.com/articles/460815

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Shenkman BS, Turtikova OV, Nemirovskaya TL, Grigoriev AI. Skeletal muscle activity and the fate of myonuclei. Acta Nat. 2010
  2. 2(2):59−66. [CrossRef] 2. MacDonald JR. Potential causes, mechanisms, and implications of post exercise hypotension. J Hum Hypertens. 2002
  3. 16(4):225−236. [CrossRef] 3. Mukai Y, Shimokawa H, Matoba T, et al. Involvement of Rho-kinase in hypertensive vascular disease: a novel therapeutic target in hypertension. FASEB J. 2001
  4. 15(6):1062−1064. [CrossRef] 4. Büyükafşar K, Arikan O, Ark M, et al. Rho-kinase expression and its contribution to the control of perfusion pressure in the isolated rat mesenteric vascular bed. Eur J Pharmacol. 2004a
  5. 485(1−3):263−268. [CrossRef] 5. Büyükafşar K, Arikan O, Ark M, Kubat H, Ozveren E. Upregulation of Rho-kinase (ROCK-2) expression and enhanced contraction to endothelin-1 in the mesenteric artery from lipopolysaccharide-treated rats. Eur J Pharmacol. 2004b
  6. 498(1−3):211−217. [CrossRef] 6. Pattabiraman PP, Inoue T, Rao PV. Elevated intraocular pressure induces Rho GTPase mediated contractile signaling in the trabecular meshwork. Exp Eye Res. 2015
  7. 29−33. [CrossRef] 7. Krauszman A, Mak TW, Szaszi K, Kuebler WM. Role of phosphatase and tensin homolog in hypoxic pulmonary vasoconstriction. Cardiovasc Res. 2017
  8. 113(8):869−878. [CrossRef] 8. Kurt AH, Büyükafşar K. Vasoconstriction induced by G1, a G-protein-coupled oestrogen receptor1 (GPER-1) agonist, in the isolated perfused rat kidney. Eur J Pharmacol. 2013
  9. 702(1−3):71−78. [CrossRef] 9. Woodside DG, Wooten DK, McIntyre BW. Adenosine diphosphate (ADP)-ribosylation of the guanosine triphosphatase (GTPase) rho in resting peripheral blood human T lymphocytes results in pseudopodial extension and the inhibition of T cell activation. J Exp Med. 1998
  10. 188(7):1211−1221. [CrossRef] 10. Shimokawa H, Sunamura S, Satoh K. RhoA/rho-kinase in the cardiovascular system. Circ Res. 2016
  11. 118(2):352−366. [CrossRef] 11. Büyükafşar K, Yalçin I, Kurt AH, et al. Rho-kinase inhibitor, Y-27632, has an antinociceptive effect in mice. Eur J Pharmacol. 2006
  12. 541(1-2):49−52. [CrossRef] 12. Festing MF. On determining sample size in experiments involving laboratory animals. Lab Anim. 2018
  13. 52(4):341−350. [CrossRef] 13. Schubert R, Kalentchuk VU, Krien U. Rho kinase inhibition partly weakens myogenic reactivity in rat small arteries by changing calcium sensitivity. Am J Physiol Heart Circ Physiol. 2002
  14. 283(6):H2288-H2295. [CrossRef] 14. D'Orléans-Juste P, Berthiaume N, Plante GE, Bkai